{"ticker": {"uuid": "05fbc4a0-0f1b-4ac4-8c02-70f909e94188", "symbol": "NOVN", "name": "Novartis AG", "exchange": "EBS", "country": "CH", "sector": "Healthcare", "industry": "Drug Manufacturers - General"}, "articles": [{"title": "Is Novartis (SWX:NOVN) Undervalued As EU Expands Approval For Its Gene Therapy?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-17T05:45:57+00:00", "published_display": "17 Jul 2026 05:45", "sentiment": "positive", "sentiment_pct": 66, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novartis stock holds steady on its global drug pipeline", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxNYkZPOTdhb0RpRV81T0dERW5PZlhjUGhTaWdmMG9aWDJjUEZObU1rSzhpVEJVdGkxX3AyeGQteGt6QlVVNUNNaHlwa2MzNjZnVWl4emhIbGdTT2gwYWhIMXZsRlNBQkpucWxFSlh4Yzg5OEhlNUNHejFveENfLURLZzIyaEZlNHI3R2hkQlBQMHJUQkdEdVIxUXY1WGxscjZBY3dGUFc3ZXNNTWRMVDBBbFVISmE?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-07-15T18:14:31+00:00", "published_display": "15 Jul 2026 18:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novartis stock. Generalized update on the Swiss drugmaker.", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxOM1MzQ3FsS2tKWDluNHB2ZlpUZnN5SWpQcXl1Tk5hY1paWFpMdWJfSkFtaEpGOUR5SmVZQ3huYUpVcE5Ua1dKVjNoUXRSTUNvWnFpQ3EyNEt3ZW9LM0RyWU9QNDNCWDFoRWU0M3Y2eFIwTmRua20tdzVoTFNIVDBrVHc4TFl4eUQtWHRTRVRrV19SX2dMOFRaWWNjbEVzYTV3RFdUNHd6MHNkM2lKZTY3bHBEUXBwZw?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-07-08T05:05:11+00:00", "published_display": "08 Jul 2026 05:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novartis (SWX:NOVN) Stock Looks Cheap on Value But Pricey After 93% Return", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxPMEM0cTBUMXZzRUFldFJSbWlyclVuSzBHSkVqYVFKMUo5MUhkLWo5empvUDZmSU00TUJEa2gyYVZUeEsyVl9tYTc3YzUydERNM0ExVFVucUY5TXJDcTVsOUxIXzRuVGE1SDg4Q3VUWUtkc0ZzVHRlbmJOVFlXbWZOZGdBdG9tNk51YUluZ0ttN3owZkVKVERZbThn?oc=5", "source_name": "Market source", "published_at": "2026-07-03T07:00:00+00:00", "published_display": "03 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novartis (SWX:NOVN) Wins EU Approval For Itvisma In A Broader SMA Market", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxQLTlqZHN5SVAzTzlNUEUxcmRtV0RQWFg2THU5VlJjOGxSSUpCTkRJMGpJVUVyZkxwZ1RXbEZaRHJyTnZwV3ZIWW5nWG1ET3NqZ1RRVXBKTTByNUppMjdOanUxNG1lX2UwOW9hVk0wOFpKdXEwSDlvc2MydEc4ZGY4Mzd2aENncWs0NGZ1OEtLZw?oc=5", "source_name": "Market source", "published_at": "2026-07-03T07:00:00+00:00", "published_display": "03 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Novartis (SWX:NOVN) Fully Valued On Its Pipeline And Margin Growth Story?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-25T07:00:00+00:00", "published_display": "25 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novartis AG (NVS): 7 Best Longevity and Anti-Aging Stocks to Buy", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxPckZUd2pEUzRHRV9vSDhhWWxEUDNHM3VMOUw5aHhoN0Z0S1FsY2t6ZjhQMEpNVlF3RVdIWjU2Rlh6X2JUd0t3U0tuV2xmUHhXUG9SZTlzTV9KcmJDaXMyODA4Skk4Z254QkhHdE5mNGl5MWczWlV0V3F3R0ZjZnZuS1NYb0JiTHRxdWcw?oc=5", "source_name": "Market source", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novartis AG Stock (CH0012005267): Analyst Targets and SMI Role Keep Shares in Focus", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxPQXRINTlTUHl3N1hEUXY2WVJaMGlJdTNzVHI3eV9LYnZFSHpUNWd5Sm1HdzBVaDBEWldQRm56ai0yOHVBbk1YdTFxckxKM1dUbDBjSjQ0cnMya0xONldUV0lXTWs2eWEyU205cVRQWnFlajk4RnEydVhzWm5FS2JoZll0dkVzMkMwZnkyQ3QzY19vMlBNWkNHNEVRWHAzRi1oQ0ViNWNMeUNlYWEtbjVMbGllRmpqX3ZHd3Z3aVQ5T1RadU56dG5WX2h3?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novartis AG Stock (CH0012005267): In focus on a quiet Sunday session", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxQYnNfWlVtN01naWlUTm5ZMGI0OTdKRFQ0VzVBeEc2RmlXTEhNbmlEaTF2Zk1qQ0hrTmRJUEplcU9IZjYyMjV6U01nd3FUMzlsdWRRMVU1Uno3ZnhYNUgwZ1ZLaDdZTnJhcF9UUXo4dngtYk9weEttcldxb0FrempLUlB5emZUdVM3dnNBMjJKY1dSTWJZUUY5Vzl3ZVBHeHdaSEhNMHcyd2pqRHBwRUZ6LWI0Y2dtandUaXF3Tm8yQXVQZw?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-06-14T07:00:00+00:00", "published_display": "14 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assessing Novartis (SWX:NOVN) Valuation After A Strong Year Of Total Shareholder Returns", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNZFF4UFRBWlhhVWhqbVdEdlRvQjBDR0JSTVZoVS1iZjRMSG5PcFUxOWlua2dpdzRlcjFIQVNTME5KZFNLSnBmMjMzbUt0bXFtYkpQRGZuNWhSc1paa3p5OElFRnUtcUZFWVY5UThVZmxEMElzUEhSXzROclRLS3puU1BVdmRtZy1CaTdUM0dYNnR3dUdPVzhxUU9yLUVMWDBUcFZkYQ?oc=5", "source_name": "Market source", "published_at": "2026-06-10T07:00:00+00:00", "published_display": "10 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novartis AG Stock (NVS) Moved Down by 3.14% on Jun 1: Key Drivers Unveiled", "summary": "", "url": "https://news.google.com/rss/articles/CBMiigFBVV95cUxNSWMxOXhqY0Y5MHFWdE5RYlZIeG8zdEQtSDdMSmxqcllNU1VBTEl5OFA1VlY5eHJiRC1scFBrdVdwTUM4UHNWU1NvckZMbGVITFVtSmgtMG8tRkxzaWZkU3FJWTFnLTMtbTBHSEJHVnBXN0dwREczU0c2eDJIQmxRX1NzUXBvNkZpUnc?oc=5", "source_name": "TradingKey", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novartis AG stock (CH0012005267): valuation metrics in focus after recent share price consolidation", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxNR3EzVzBPdVRHVW5tcVNka25NRkdvMkZUUUwycmEwOHBJYzRwcl9KNDRIQWpyMlFta0NZQ2xKTm5lQnRJVlNSaG1EMGZFbzBjejhjUEJvQkRmWkRianpOeXNZLXR4clZKeUlfQ2pHaXRmalFzQ2ZjMU8tTTBLSkJ5eUxwOWFGeFd3dktrZktlNXVsM2tlWTR2dFF3Y3FuRkdKR2V0YmEzVVQyVlNvcFhSUkU5Q05xclJsTEQyTmNBRnBCYzJFQ3NrSQ?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-05-29T07:00:00+00:00", "published_display": "29 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novartis AG stock (CH0012005267): shares little changed as investors digest Swiss pharma group\u2019s s", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxQekExTlFTbHJWZjRIOGdZMlBxbFdxUDdsaDBZTTVjaXdSaTRrbEs1RGpfNDhYa3ZQZnRERWIxdkcwbnBnMnhJWEJSZU00aXBKT294VTdFWjJTdlprQTBxQU0zQ2ZnN0lBRUlmclloN2hGeHYtLXV3MTk2WHo5NXJ0MXZkOVRMcmlMYkFwWEJJOFJSQmxReE5kM01tbFFnOFdKWHBfTGhORGRMVUptMlpnMHFic0FGaWtyaE5KbWl0LTBfZw?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-05-28T07:00:00+00:00", "published_display": "28 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novartis AG stock (CH0012005267): Spin-off, oncology focus and pipeline updates in the spotlight", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxQeEdad2ZuTFVSTkVRTjZJb0FRT0s0LUhaY3piU3J5WUQyeVhOMlNOOElRN1M2MU5aTzVJRkdieTZWLXRCelBqY09VSzF4Q3lmdUJCMlF0Ujd2bERCZWR1blJlaEJjbFZUcWdnb3FJOE1FeXA0NTl4dWE2MlNRSndqTnFwSzYyWjJfVU4wdEJ1aTQzQnNnT0UyQTdxd0xidDBiSWpNSElneWQ2WlMyR05wMDZ2R2FzZnNveHh0bi0xSExTNW5U?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novartis AG stock (CH0012005267): pipeline progress and steady demand keep pharma giant in focus", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxNb1F2RkZ4VzllMTZJaWgxZlNHS1RZUkF3WllvVDRaNGFnRTRoTmZFaU9ZVGZlRUU5THliUFltSFVlRXM5UHBUbjk5TW1PMUNnNEc1aGhfblVqbVBmbG1JSWZyNWFuNXNsVzI3a1UzSUw0N3BRVHJyWlltNXE5bzNOeXVSb0ZrNHRIYXhhcFRtTks3bDJ0M2FHZWtUMzMtY24takEwQ0VBdWdSbzYyN3FWczk3YU5lRDFta05xN09UR0FPWkE2S21UTmh3?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-05-24T07:00:00+00:00", "published_display": "24 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novartis stock (CH0012005267): U.S. drug pipeline and recent catalyst watch", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxNUmJxb2xxQk42TUFPa0tTeGFDdVkydm9VOWdKRHRzWE9Nck1XMTJ5aDJkVGIxeXRxWlhScDNNYm1EdTNkSlBxVGZwMGItVGNyZWk4VmlQRHc0c2RSRnJJZ0QzcFlBSEItQ09XUjJBUk04WVNXX3hBblBMdmVvX3hzaTF5dlRVNTJLTEJWdkdiZFEwUWs1SzF4UjhkREZnZzNpY2RXUUYxbWdoS2hPX1huenpWN1F2QUkxMTFTOFBzTmRUQQ?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-05-19T07:00:00+00:00", "published_display": "19 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novartis (SWX:NOVN) Valuation Check After New Pluvicto PSMAddition Study Data And Regulatory Filings", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxQUjZnU0Vzc3FUbEdnODJWWXc0YlJDeUV0d2MwZGFCV2NuNlR4OUZzMW1lelNFTkg3MWFIN1ZveWE3YVRjMVgwRmpjWFhZRkpSeV9pUXFodDFROXU0N0g4eFpiQlhpR3kyOWxvWnR0S0JZekJMalRudUhkM1hPNG1qdjVnbzRTNXdpQXktbGVXWGJkamRkdXJFX0xSSl9OQ3ZBN0dKdA?oc=5", "source_name": "Market source", "published_at": "2026-05-19T07:00:00+00:00", "published_display": "19 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novartis AG stock (CH0012005267): dividend profile and pipeline focus move into the spotlight", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxNanM3QVZCWDV3TlZ5NjN4Y3NKbE9aV0liamc5QzFFX1dLWkw3SV9PZ1ZiSWU3YmlyY0duMXR1emZaLWhnM0V4RWN4R00yZkxiRU1YWWR2WHJrZnFrNHFDdlB5LXJnSVFERFBiZ2xUM05zdHk1ZUlTZWJvejJNX2NCVC0wMUk2QXRyNXNKRTJBRWppbmVmSzBRb1k5STdjQUJ4ay1MeTdYOEZWb29oZ3dFbWYwUVZ0YXV1aTN3TEJudTdZTThRNWgxVWt3?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-05-16T07:00:00+00:00", "published_display": "16 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novartis stock (CH0012005267): Q1 2026 earnings show blockbuster growth amid patent headwinds", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxNZ25Qay1aS0NrX3Y3em93bDNBSWcyMlRUNlBlc2c5RnNWWUo2bG9qbDNaNlB5OHlybklPYWNFY0lZa2R6SUIxbWZzYmdBN3VGLU5DSHlkak5pVG1COTltYmRVWkJ2Um9MRmJtZHpwR013N2hjdkhtNUpGZDJJRTVPVnBzMVd2dWpMaGctdlpCZXlMWjdjQUVFSXZ2cWgzNGhubVNJQWd4QURTUU1kWHF6S2ZiRW1mLTBGYjlPU0xqV0FUWUVCVnc?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-05-12T07:00:00+00:00", "published_display": "12 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novartis AG stock (CH0012005267): Mixed Q1 2026 results across pharma peers highlight sector dynamic", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxNOWNCMURhUlh6VjQyZF9MYXRPN3h1WDVwenFoV1plY1lMVHZsbkt1RVlrSTRvUHZ3MWtqQ0laM1J6emJkWU5zd2QwNHluZ1BqTGlmMEZWVkNETl85TFBxOU03d3VGYjRvT2dUYlZSbTV5VVh6X2ZTSW8yZ3ROWWJweGRGc09QWmtiOUhOdHJTbldOWmtMYWkwLWpYOUptdGJ3X3kycVBKLXNrbkxwMExXMFFTWXpodkJUUG5kVDQyRnRUSVU?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-05-12T07:00:00+00:00", "published_display": "12 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novartis AG stock (CH0012005267): Global pharma leader navigates patent cliffs", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxOY2JmMmxHd3RwbWZ0SEhmWVJDbWdOeDViN1c5dGxvWjV3bTVwWWNyZm5EdThQTzQ4ZlRwU3E0M3Z0b0habXNDQ2V6X25LVklacTY2YjFvR1BMdC1uRW44UXMtNzl6WG1VSHBRZEs5dGNwY2RIaVJHT2duaTdfLWNVYlhmOG5YczdYTTZzZGxJeFhSSGxsa1VkLXJSXzZzS2d6LUdYYU5oSVF2WURMTngxUWlWN2ptWTIzMTFxZkRnNHpuYjF0dmc?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is It Too Late To Consider Novartis (SWX:NOVN) After Its Strong 1-Year Share Price Run?", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxNUUFITElOR3ZqS1hyNHdkV3FYYTNzRmhMNWNTbDhCSVVkU1JVbzNVajNFVjN0dC1oQ09JcnZTdFhZVzBBdDhnS3lJb1BJNHN4OG94ODhwenRLNjJhZGoxa1M3bmlCenA2eE44c01oeWFVa2dfQWxOSDQ5Y2xxWGFhVThMYmtENG9RVzB2Qk92UGR5eUNJem1OTGZ2bw?oc=5", "source_name": "Market source", "published_at": "2026-05-10T07:00:00+00:00", "published_display": "10 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novartis AG stock (CH0012005267): Q1 2026 results miss EPS consensus as revenue dips slightly year?o", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxPeDdMR1VoTl9xR3c1NVJ6T0ZORklWaXFKN1VzbTJTTUhMNUhvT0JhenVGMG5Ec250SWFqYmloc2FfZ0xVelh1UVRXckpyNVhPVDZCM1RXWEVCUUhZdkM3YW9ZaFFQakdIdVJjaUNMdzhydzl3bzg1YkdDcUk2Zlctbl9wWHBKbDA3dnZoeTJNTnVUZTNmWU84WUthaUlMck5rN3hhaUJZOWIxUTF0RTRWeExsWTB5Z005dXAtT29meHFTdmxJbHc?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-05-08T07:00:00+00:00", "published_display": "08 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is It Too Late To Consider Novartis (SWX:NOVN) After Its 3 Year 41.9% Rise?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-06T07:00:00+00:00", "published_display": "06 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here's What Analysts Are Forecasting For Novartis AG (VTX:NOVN) After Its First-Quarter Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxPZjhSbVpzdjBVVjQyaVRLN0hqTGZoS0NOV0pIem5GYjQtekJkekhkQ1dnTnFYVXp5Vy1jdjBzTzNTV083RFNDMlVyYlQ5dHVvcDUybDdiWHJwMktfMnIxZTd5OXR2TEdvMjZyY2xsbEZXUVRWWlowMEc1VlU3Z2E5cUVkVF9QbDJrRkhPa0dRamZNNmkwamFJcnNJVUNGMVQ5N09lbURn?oc=5", "source_name": "Market source", "published_at": "2026-05-01T07:00:00+00:00", "published_display": "01 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novartis AG (NVS) Stock Up 3.4% but GF Value Says Overvalued -- GF Score: 83/100", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxPaF8yY1ZZM2tYUDgzZnVERDRxSmFkcHRxQzkyQ291Z0JwekVPVTkzMThiQkxOb3Rtb04yTjBadlY4em50LWlVZ080UWFHNjJNZUUtS1JMell6YlpMbzNGdFhFVEhFd1ZyYkFWd0Q0RFVHZTJuRTRTay0xS01tdVZTNFYxbjdDeU42cERQZlB3TmlBb09yRVpDQTRGOFFXRjRYZDdUcVhnbGJIcWNfM3l6NnVvNFFQRkhRUGJMQnk2VQ?oc=5", "source_name": "GuruFocus", "published_at": "2026-04-30T07:00:00+00:00", "published_display": "30 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is It Too Late To Consider Novartis (SWX:NOVN) After Its 30% One-Year Rally?", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxQX3BjRmtsekpqWk1QNXhDVnFOOFFJcHFjSGNqT0lWZmFIdnJJM3NqdWlNRUwtVnBaa1g3OF9ObGFuaXVnZ052R2RNazIxWmRrckVYMkNBRnN1Wkt5VXBXOW5QZ05oWUctcWZsWkNtV25QejZIZzdvVkJ2RVhxdFVQOTJCajlTQ3dTeHdPRWhOT1U3bTdJX0RxM205X0N1ZFVB?oc=5", "source_name": "Market source", "published_at": "2026-04-23T07:00:00+00:00", "published_display": "23 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assessing Novartis (SWX:NOVN) Valuation After Recent Share Price Moves And Long Term Returns", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxQcldxRGFOelJJZjRoeUJ4U1NtNzhIM1NFY1M3OXpHc3R3eUFYRG9jbUx6djU4Uk9Fa09hdWVDVUx4c0huZU5zUnUyWl9ITnpWR255Tl9XS0FUU2tVRWptSEo0TEl5VjQwc3BzTWU2TTJRUlJxTDBHeW9xWWhtVXJ2ZlVvTF9aTHdYRUE2YjRLcTNJNXlzdkkybm5PQ3poSmZNaGlSZw?oc=5", "source_name": "Market source", "published_at": "2026-04-19T07:00:00+00:00", "published_display": "19 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assessing Novartis (SWX:NOVN) Valuation After Recent Mixed Share Price Performance", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNWEYwQTZEZ3M3Y3hZUHMtV213SUQ3R0pOU2R4clJJcG1hUkVFaHgzdkw5cHRzOWRiYm9HT2V5Y09VUlJKdlREMkFScXdvWEx0azZydFBHQlhCRHQxdnVKQTFKeU5vRFRpbFd3elI4Wno3LXBBbl9zNl9EMG5SUjB0OFIwOGV0dVd3LS1jcExfeGVkVWZLUzJqOXlrM2FNcWJiV2pubg?oc=5", "source_name": "Market source", "published_at": "2026-03-27T07:00:00+00:00", "published_display": "27 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novartis India shares soar 20% as Swiss parent plans full exit in Rs 1,446 crore deal", "summary": "", "url": "https://news.google.com/rss/articles/CBMi-AFBVV95cUxQOWRNMXAwUjJNUWx0NHYwaXB3Qmh5UDItM1BzR2hBMjNyV3hHV2IwZ1lITUVwdjJRak94THdEaWFvU09tMUZubEwwejN6T2ZfdXNQdnU2REhkV3FrRzJicFlsM3lacmF3ZnRpdUtheEk2Y0E5Z1B4QW81UTVfRDV2VUtNZ0tpdjlrWjdodGwtSHZCdkc1TlRsUlgtQTJRYWl3cTBtaXE1SVVxd1lSelBSdUVya1JndWdDZi1VNXkwNUdpN2JvMGpoOXJlYlNOeFUwS3dDRUtocE50MExkZXRNclJaWDAwZHBxVGp6YjRxRHJNdmRTeFBENtIB_gFBVV95cUxQQjRfTjBUaVdDcGxPSzIxVmZMUDRqUWdra0pkdUZSM0UtWm1FY2w4dVNqZGNNTlYyRmI0Vm9uOGVfaWljSXJJWkd1NG40UWRlUVlLUmpWbzZVblR4dzJuUnY2ODRTaW9UaV96bGFLRzJjaU41a1B4Y1BiMHRxMTNHRjJhLXRWWm1pVVlTWUxRLU5jSno2dV8xTlhRT1JMcXJ4TzA3V1lTSlg5VXNGOE1xRTZOSHhVNm1TdW0xcWw0Nk9ENDZxNmtjdGFSWGhadkljY2hRbHA3UC1vMUl6a1B0T3BSckVEdDNlWUVnQV9Nb2gyVVhBd0gzRkhNMjBkdw?oc=5", "source_name": "The Economic Times", "published_at": "2026-02-20T08:00:00+00:00", "published_display": "20 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novartis India shares zoom on Swiss parent\u2019s \u20b91,446 cr. exit plan", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The Hindu", "published_at": "2026-02-20T08:00:00+00:00", "published_display": "20 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novartis shares hit 20% upper circuit as Swiss parent to sell entire stake", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Business Standard", "published_at": "2026-02-20T08:00:00+00:00", "published_display": "20 Feb 2026 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Should Vanrafia Kidney Data and Dividend Move Reshape the Novartis (SWX:NOVN) Autoimmune Investment Case?", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxOeHR5SFlIS2Q4QlNNLWItS1pHd0F4WnhzY3lGYWszUFo0WUc0TjR4akQ0RnVzMU93Sk5RZEtDekN0WUVGb0U0aF83by1zUDlhZU0zQ1lzNGlYbjNValM0cGtVRDg5SzlPdHVKN19zSXFEcmxuemhKcjA2ZjNmWVlWSmwwMnQtbG8?oc=5", "source_name": "Market source", "published_at": "2026-02-15T08:00:00+00:00", "published_display": "15 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is It Too Late To Consider Novartis (SWX:NOVN) After Strong Multi\u2011Year Share Gains?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiggFBVV95cUxOcjd5c28tUDdHbFRneEQ1OTFGU01IOEUzaVFUWEZEWmlyYVFLX1p1aHo4ZEdKaTZ1UkE1LVpnZEU3TUhNZVAyandac0Y3SjhteGVwNlB0WDJySG9HdzZTY0RNWU9PN0JxN3NtWkVSazFPU1ZUWGZsZkxxaXBvclpiQWVn?oc=5", "source_name": "Market source", "published_at": "2026-02-14T08:00:00+00:00", "published_display": "14 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novartis' (VTX:NOVN) Shareholders Will Receive A Bigger Dividend Than Last Year", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxPek5mLWVIZDRPSmRpWTVmaHE0Vi1OUVVxS1dhSHRwR0E0WkdYbXpQOTVFVXBXWmdUUTkydjBUS3l1U1FSa3JNOHV2YVlhX3dkZ1FvbkFUNjFpa2pZUnA3dXdXX2hMVUFVVXkyZmNvRC13QXQ3aEZTLXFBai1CUE11aG0zSGRJVDlpamtjUw?oc=5", "source_name": "Market source", "published_at": "2026-02-08T08:00:00+00:00", "published_display": "08 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novartis AG (VTX:NOVN) Just Reported Full-Year Earnings: Have Analysts Changed Their Mind On The Stock?", "summary": "", "url": "https://news.google.com/rss/articles/CBMie0FVX3lxTE9lMEVYUDY1clJIN085NXQ3Vkh5RjRyZWNoYlZKQ2lZMktBWWtlVjZSSzJCT1JJOGJHVjM3dWZnYjdsaFU4WVhMNk53NFpHSzVfXzJpSzk3RW5WZVJ3LVhhTzU0cm5ad2djc0VOR1VoSS1uei1VSUloTkkzMA?oc=5", "source_name": "Market source", "published_at": "2026-02-07T08:00:00+00:00", "published_display": "07 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Novartis (SWX:NOVN) Attractive After Strong Multi Year Share Price Performance", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxQWVNCRzJaY3lpcDhHUmlGdXRFUXZ4MDVDdmlSdV9VSTlXUDBvR2pmcnB5Z0VCcUszdWFmTWhRU0x0QkpiU3dMenhMUlFIM3JSNmplc3pVQ1J3RDZ5dDBCaFdoekJnU2k5dUFocUlZRnZxMFFpTVZFNXRoRFlkeGRoQnlYaW9kUDk3?oc=5", "source_name": "Market source", "published_at": "2026-01-31T08:00:00+00:00", "published_display": "31 Jan 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is It Time To Reconsider Novartis (SWX:NOVN) After Its Recent Share Price Gains?", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxPUkpBYjVuUTlaaE9KcUhIc0tkTEZ4U3BWZG41V3pjazRVb1gxT0M0MVY3YnB5SThubkVRR3AzaERZazBsUnI2MmZQZHN6V2ZqRnJISGhQX3hLS0Y3anVqTGFoeVlGbFpwMmVicHYtZ0hURS14cU9iakZmamdqc1RzWFg4bVJPQQ?oc=5", "source_name": "Market source", "published_at": "2026-01-10T08:00:00+00:00", "published_display": "10 Jan 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novartis Stock Forecast: What\u2019s Driving NOVN and Where It Could Go Next", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxQWWI0MXNIMk9WZkUwQ1FSTHlXTlVrdURVaVp2ZXZNMUlqU2FKbUdFQnpsdVk0TGR0NnRGakNqbkx2TmRKRzlrdkVzazVxM2JfczF6Ym5taVEwblpQdndVU1p3QVczbzUyOHhvYXFfQUZJOHFKVGxqWjVMWVFqbWR1bzZRTG1FaUxEMVBvMGtoal9yYWpZUjJieDR3MA?oc=5", "source_name": "TIKR.com", "published_at": "2025-10-24T07:00:00+00:00", "published_display": "24 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Is Novartis (SWX:NOVN) Undervalued As EU Expands Approval For Its Gene Therapy?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-17T05:45:57+00:00", "published_display": "17 Jul 2026 05:45", "sentiment": "positive", "sentiment_pct": 66, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novartis stock holds steady on its global drug pipeline", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxNYkZPOTdhb0RpRV81T0dERW5PZlhjUGhTaWdmMG9aWDJjUEZObU1rSzhpVEJVdGkxX3AyeGQteGt6QlVVNUNNaHlwa2MzNjZnVWl4emhIbGdTT2gwYWhIMXZsRlNBQkpucWxFSlh4Yzg5OEhlNUNHejFveENfLURLZzIyaEZlNHI3R2hkQlBQMHJUQkdEdVIxUXY1WGxscjZBY3dGUFc3ZXNNTWRMVDBBbFVISmE?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-07-15T18:14:31+00:00", "published_display": "15 Jul 2026 18:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novartis stock. Generalized update on the Swiss drugmaker.", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxOM1MzQ3FsS2tKWDluNHB2ZlpUZnN5SWpQcXl1Tk5hY1paWFpMdWJfSkFtaEpGOUR5SmVZQ3huYUpVcE5Ua1dKVjNoUXRSTUNvWnFpQ3EyNEt3ZW9LM0RyWU9QNDNCWDFoRWU0M3Y2eFIwTmRua20tdzVoTFNIVDBrVHc4TFl4eUQtWHRTRVRrV19SX2dMOFRaWWNjbEVzYTV3RFdUNHd6MHNkM2lKZTY3bHBEUXBwZw?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-07-08T05:05:11+00:00", "published_display": "08 Jul 2026 05:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novartis (SWX:NOVN) Stock Looks Cheap on Value But Pricey After 93% Return", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxPMEM0cTBUMXZzRUFldFJSbWlyclVuSzBHSkVqYVFKMUo5MUhkLWo5empvUDZmSU00TUJEa2gyYVZUeEsyVl9tYTc3YzUydERNM0ExVFVucUY5TXJDcTVsOUxIXzRuVGE1SDg4Q3VUWUtkc0ZzVHRlbmJOVFlXbWZOZGdBdG9tNk51YUluZ0ttN3owZkVKVERZbThn?oc=5", "source_name": "Market source", "published_at": "2026-07-03T07:00:00+00:00", "published_display": "03 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novartis (SWX:NOVN) Wins EU Approval For Itvisma In A Broader SMA Market", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxQLTlqZHN5SVAzTzlNUEUxcmRtV0RQWFg2THU5VlJjOGxSSUpCTkRJMGpJVUVyZkxwZ1RXbEZaRHJyTnZwV3ZIWW5nWG1ET3NqZ1RRVXBKTTByNUppMjdOanUxNG1lX2UwOW9hVk0wOFpKdXEwSDlvc2MydEc4ZGY4Mzd2aENncWs0NGZ1OEtLZw?oc=5", "source_name": "Market source", "published_at": "2026-07-03T07:00:00+00:00", "published_display": "03 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Novartis (SWX:NOVN) Fully Valued On Its Pipeline And Margin Growth Story?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-25T07:00:00+00:00", "published_display": "25 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novartis AG (NVS): 7 Best Longevity and Anti-Aging Stocks to Buy", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxPckZUd2pEUzRHRV9vSDhhWWxEUDNHM3VMOUw5aHhoN0Z0S1FsY2t6ZjhQMEpNVlF3RVdIWjU2Rlh6X2JUd0t3U0tuV2xmUHhXUG9SZTlzTV9KcmJDaXMyODA4Skk4Z254QkhHdE5mNGl5MWczWlV0V3F3R0ZjZnZuS1NYb0JiTHRxdWcw?oc=5", "source_name": "Market source", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novartis AG Stock (CH0012005267): Analyst Targets and SMI Role Keep Shares in Focus", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxPQXRINTlTUHl3N1hEUXY2WVJaMGlJdTNzVHI3eV9LYnZFSHpUNWd5Sm1HdzBVaDBEWldQRm56ai0yOHVBbk1YdTFxckxKM1dUbDBjSjQ0cnMya0xONldUV0lXTWs2eWEyU205cVRQWnFlajk4RnEydVhzWm5FS2JoZll0dkVzMkMwZnkyQ3QzY19vMlBNWkNHNEVRWHAzRi1oQ0ViNWNMeUNlYWEtbjVMbGllRmpqX3ZHd3Z3aVQ5T1RadU56dG5WX2h3?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novartis AG Stock (CH0012005267): In focus on a quiet Sunday session", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxQYnNfWlVtN01naWlUTm5ZMGI0OTdKRFQ0VzVBeEc2RmlXTEhNbmlEaTF2Zk1qQ0hrTmRJUEplcU9IZjYyMjV6U01nd3FUMzlsdWRRMVU1Uno3ZnhYNUgwZ1ZLaDdZTnJhcF9UUXo4dngtYk9weEttcldxb0FrempLUlB5emZUdVM3dnNBMjJKY1dSTWJZUUY5Vzl3ZVBHeHdaSEhNMHcyd2pqRHBwRUZ6LWI0Y2dtandUaXF3Tm8yQXVQZw?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-06-14T07:00:00+00:00", "published_display": "14 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assessing Novartis (SWX:NOVN) Valuation After A Strong Year Of Total Shareholder Returns", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNZFF4UFRBWlhhVWhqbVdEdlRvQjBDR0JSTVZoVS1iZjRMSG5PcFUxOWlua2dpdzRlcjFIQVNTME5KZFNLSnBmMjMzbUt0bXFtYkpQRGZuNWhSc1paa3p5OElFRnUtcUZFWVY5UThVZmxEMElzUEhSXzROclRLS3puU1BVdmRtZy1CaTdUM0dYNnR3dUdPVzhxUU9yLUVMWDBUcFZkYQ?oc=5", "source_name": "Market source", "published_at": "2026-06-10T07:00:00+00:00", "published_display": "10 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novartis AG Stock (NVS) Moved Down by 3.14% on Jun 1: Key Drivers Unveiled", "summary": "", "url": "https://news.google.com/rss/articles/CBMiigFBVV95cUxNSWMxOXhqY0Y5MHFWdE5RYlZIeG8zdEQtSDdMSmxqcllNU1VBTEl5OFA1VlY5eHJiRC1scFBrdVdwTUM4UHNWU1NvckZMbGVITFVtSmgtMG8tRkxzaWZkU3FJWTFnLTMtbTBHSEJHVnBXN0dwREczU0c2eDJIQmxRX1NzUXBvNkZpUnc?oc=5", "source_name": "TradingKey", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novartis AG stock (CH0012005267): valuation metrics in focus after recent share price consolidation", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxNR3EzVzBPdVRHVW5tcVNka25NRkdvMkZUUUwycmEwOHBJYzRwcl9KNDRIQWpyMlFta0NZQ2xKTm5lQnRJVlNSaG1EMGZFbzBjejhjUEJvQkRmWkRianpOeXNZLXR4clZKeUlfQ2pHaXRmalFzQ2ZjMU8tTTBLSkJ5eUxwOWFGeFd3dktrZktlNXVsM2tlWTR2dFF3Y3FuRkdKR2V0YmEzVVQyVlNvcFhSUkU5Q05xclJsTEQyTmNBRnBCYzJFQ3NrSQ?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-05-29T07:00:00+00:00", "published_display": "29 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novartis AG stock (CH0012005267): shares little changed as investors digest Swiss pharma group\u2019s s", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxQekExTlFTbHJWZjRIOGdZMlBxbFdxUDdsaDBZTTVjaXdSaTRrbEs1RGpfNDhYa3ZQZnRERWIxdkcwbnBnMnhJWEJSZU00aXBKT294VTdFWjJTdlprQTBxQU0zQ2ZnN0lBRUlmclloN2hGeHYtLXV3MTk2WHo5NXJ0MXZkOVRMcmlMYkFwWEJJOFJSQmxReE5kM01tbFFnOFdKWHBfTGhORGRMVUptMlpnMHFic0FGaWtyaE5KbWl0LTBfZw?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-05-28T07:00:00+00:00", "published_display": "28 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novartis AG stock (CH0012005267): Spin-off, oncology focus and pipeline updates in the spotlight", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxQeEdad2ZuTFVSTkVRTjZJb0FRT0s0LUhaY3piU3J5WUQyeVhOMlNOOElRN1M2MU5aTzVJRkdieTZWLXRCelBqY09VSzF4Q3lmdUJCMlF0Ujd2bERCZWR1blJlaEJjbFZUcWdnb3FJOE1FeXA0NTl4dWE2MlNRSndqTnFwSzYyWjJfVU4wdEJ1aTQzQnNnT0UyQTdxd0xidDBiSWpNSElneWQ2WlMyR05wMDZ2R2FzZnNveHh0bi0xSExTNW5U?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novartis AG stock (CH0012005267): pipeline progress and steady demand keep pharma giant in focus", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxNb1F2RkZ4VzllMTZJaWgxZlNHS1RZUkF3WllvVDRaNGFnRTRoTmZFaU9ZVGZlRUU5THliUFltSFVlRXM5UHBUbjk5TW1PMUNnNEc1aGhfblVqbVBmbG1JSWZyNWFuNXNsVzI3a1UzSUw0N3BRVHJyWlltNXE5bzNOeXVSb0ZrNHRIYXhhcFRtTks3bDJ0M2FHZWtUMzMtY24takEwQ0VBdWdSbzYyN3FWczk3YU5lRDFta05xN09UR0FPWkE2S21UTmh3?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-05-24T07:00:00+00:00", "published_display": "24 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novartis stock (CH0012005267): U.S. drug pipeline and recent catalyst watch", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxNUmJxb2xxQk42TUFPa0tTeGFDdVkydm9VOWdKRHRzWE9Nck1XMTJ5aDJkVGIxeXRxWlhScDNNYm1EdTNkSlBxVGZwMGItVGNyZWk4VmlQRHc0c2RSRnJJZ0QzcFlBSEItQ09XUjJBUk04WVNXX3hBblBMdmVvX3hzaTF5dlRVNTJLTEJWdkdiZFEwUWs1SzF4UjhkREZnZzNpY2RXUUYxbWdoS2hPX1huenpWN1F2QUkxMTFTOFBzTmRUQQ?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-05-19T07:00:00+00:00", "published_display": "19 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novartis (SWX:NOVN) Valuation Check After New Pluvicto PSMAddition Study Data And Regulatory Filings", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxQUjZnU0Vzc3FUbEdnODJWWXc0YlJDeUV0d2MwZGFCV2NuNlR4OUZzMW1lelNFTkg3MWFIN1ZveWE3YVRjMVgwRmpjWFhZRkpSeV9pUXFodDFROXU0N0g4eFpiQlhpR3kyOWxvWnR0S0JZekJMalRudUhkM1hPNG1qdjVnbzRTNXdpQXktbGVXWGJkamRkdXJFX0xSSl9OQ3ZBN0dKdA?oc=5", "source_name": "Market source", "published_at": "2026-05-19T07:00:00+00:00", "published_display": "19 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novartis AG stock (CH0012005267): dividend profile and pipeline focus move into the spotlight", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxNanM3QVZCWDV3TlZ5NjN4Y3NKbE9aV0liamc5QzFFX1dLWkw3SV9PZ1ZiSWU3YmlyY0duMXR1emZaLWhnM0V4RWN4R00yZkxiRU1YWWR2WHJrZnFrNHFDdlB5LXJnSVFERFBiZ2xUM05zdHk1ZUlTZWJvejJNX2NCVC0wMUk2QXRyNXNKRTJBRWppbmVmSzBRb1k5STdjQUJ4ay1MeTdYOEZWb29oZ3dFbWYwUVZ0YXV1aTN3TEJudTdZTThRNWgxVWt3?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-05-16T07:00:00+00:00", "published_display": "16 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novartis stock (CH0012005267): Q1 2026 earnings show blockbuster growth amid patent headwinds", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxNZ25Qay1aS0NrX3Y3em93bDNBSWcyMlRUNlBlc2c5RnNWWUo2bG9qbDNaNlB5OHlybklPYWNFY0lZa2R6SUIxbWZzYmdBN3VGLU5DSHlkak5pVG1COTltYmRVWkJ2Um9MRmJtZHpwR013N2hjdkhtNUpGZDJJRTVPVnBzMVd2dWpMaGctdlpCZXlMWjdjQUVFSXZ2cWgzNGhubVNJQWd4QURTUU1kWHF6S2ZiRW1mLTBGYjlPU0xqV0FUWUVCVnc?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-05-12T07:00:00+00:00", "published_display": "12 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novartis AG stock (CH0012005267): Mixed Q1 2026 results across pharma peers highlight sector dynamic", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxNOWNCMURhUlh6VjQyZF9MYXRPN3h1WDVwenFoV1plY1lMVHZsbkt1RVlrSTRvUHZ3MWtqQ0laM1J6emJkWU5zd2QwNHluZ1BqTGlmMEZWVkNETl85TFBxOU03d3VGYjRvT2dUYlZSbTV5VVh6X2ZTSW8yZ3ROWWJweGRGc09QWmtiOUhOdHJTbldOWmtMYWkwLWpYOUptdGJ3X3kycVBKLXNrbkxwMExXMFFTWXpodkJUUG5kVDQyRnRUSVU?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-05-12T07:00:00+00:00", "published_display": "12 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novartis AG stock (CH0012005267): Global pharma leader navigates patent cliffs", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxOY2JmMmxHd3RwbWZ0SEhmWVJDbWdOeDViN1c5dGxvWjV3bTVwWWNyZm5EdThQTzQ4ZlRwU3E0M3Z0b0habXNDQ2V6X25LVklacTY2YjFvR1BMdC1uRW44UXMtNzl6WG1VSHBRZEs5dGNwY2RIaVJHT2duaTdfLWNVYlhmOG5YczdYTTZzZGxJeFhSSGxsa1VkLXJSXzZzS2d6LUdYYU5oSVF2WURMTngxUWlWN2ptWTIzMTFxZkRnNHpuYjF0dmc?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is It Too Late To Consider Novartis (SWX:NOVN) After Its Strong 1-Year Share Price Run?", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxNUUFITElOR3ZqS1hyNHdkV3FYYTNzRmhMNWNTbDhCSVVkU1JVbzNVajNFVjN0dC1oQ09JcnZTdFhZVzBBdDhnS3lJb1BJNHN4OG94ODhwenRLNjJhZGoxa1M3bmlCenA2eE44c01oeWFVa2dfQWxOSDQ5Y2xxWGFhVThMYmtENG9RVzB2Qk92UGR5eUNJem1OTGZ2bw?oc=5", "source_name": "Market source", "published_at": "2026-05-10T07:00:00+00:00", "published_display": "10 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novartis AG stock (CH0012005267): Q1 2026 results miss EPS consensus as revenue dips slightly year?o", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxPeDdMR1VoTl9xR3c1NVJ6T0ZORklWaXFKN1VzbTJTTUhMNUhvT0JhenVGMG5Ec250SWFqYmloc2FfZ0xVelh1UVRXckpyNVhPVDZCM1RXWEVCUUhZdkM3YW9ZaFFQakdIdVJjaUNMdzhydzl3bzg1YkdDcUk2Zlctbl9wWHBKbDA3dnZoeTJNTnVUZTNmWU84WUthaUlMck5rN3hhaUJZOWIxUTF0RTRWeExsWTB5Z005dXAtT29meHFTdmxJbHc?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-05-08T07:00:00+00:00", "published_display": "08 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is It Too Late To Consider Novartis (SWX:NOVN) After Its 3 Year 41.9% Rise?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-06T07:00:00+00:00", "published_display": "06 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here's What Analysts Are Forecasting For Novartis AG (VTX:NOVN) After Its First-Quarter Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxPZjhSbVpzdjBVVjQyaVRLN0hqTGZoS0NOV0pIem5GYjQtekJkekhkQ1dnTnFYVXp5Vy1jdjBzTzNTV083RFNDMlVyYlQ5dHVvcDUybDdiWHJwMktfMnIxZTd5OXR2TEdvMjZyY2xsbEZXUVRWWlowMEc1VlU3Z2E5cUVkVF9QbDJrRkhPa0dRamZNNmkwamFJcnNJVUNGMVQ5N09lbURn?oc=5", "source_name": "Market source", "published_at": "2026-05-01T07:00:00+00:00", "published_display": "01 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novartis AG (NVS) Stock Up 3.4% but GF Value Says Overvalued -- GF Score: 83/100", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxPaF8yY1ZZM2tYUDgzZnVERDRxSmFkcHRxQzkyQ291Z0JwekVPVTkzMThiQkxOb3Rtb04yTjBadlY4em50LWlVZ080UWFHNjJNZUUtS1JMell6YlpMbzNGdFhFVEhFd1ZyYkFWd0Q0RFVHZTJuRTRTay0xS01tdVZTNFYxbjdDeU42cERQZlB3TmlBb09yRVpDQTRGOFFXRjRYZDdUcVhnbGJIcWNfM3l6NnVvNFFQRkhRUGJMQnk2VQ?oc=5", "source_name": "GuruFocus", "published_at": "2026-04-30T07:00:00+00:00", "published_display": "30 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is It Too Late To Consider Novartis (SWX:NOVN) After Its 30% One-Year Rally?", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxQX3BjRmtsekpqWk1QNXhDVnFOOFFJcHFjSGNqT0lWZmFIdnJJM3NqdWlNRUwtVnBaa1g3OF9ObGFuaXVnZ052R2RNazIxWmRrckVYMkNBRnN1Wkt5VXBXOW5QZ05oWUctcWZsWkNtV25QejZIZzdvVkJ2RVhxdFVQOTJCajlTQ3dTeHdPRWhOT1U3bTdJX0RxM205X0N1ZFVB?oc=5", "source_name": "Market source", "published_at": "2026-04-23T07:00:00+00:00", "published_display": "23 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assessing Novartis (SWX:NOVN) Valuation After Recent Share Price Moves And Long Term Returns", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxQcldxRGFOelJJZjRoeUJ4U1NtNzhIM1NFY1M3OXpHc3R3eUFYRG9jbUx6djU4Uk9Fa09hdWVDVUx4c0huZU5zUnUyWl9ITnpWR255Tl9XS0FUU2tVRWptSEo0TEl5VjQwc3BzTWU2TTJRUlJxTDBHeW9xWWhtVXJ2ZlVvTF9aTHdYRUE2YjRLcTNJNXlzdkkybm5PQ3poSmZNaGlSZw?oc=5", "source_name": "Market source", "published_at": "2026-04-19T07:00:00+00:00", "published_display": "19 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assessing Novartis (SWX:NOVN) Valuation After Recent Mixed Share Price Performance", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNWEYwQTZEZ3M3Y3hZUHMtV213SUQ3R0pOU2R4clJJcG1hUkVFaHgzdkw5cHRzOWRiYm9HT2V5Y09VUlJKdlREMkFScXdvWEx0azZydFBHQlhCRHQxdnVKQTFKeU5vRFRpbFd3elI4Wno3LXBBbl9zNl9EMG5SUjB0OFIwOGV0dVd3LS1jcExfeGVkVWZLUzJqOXlrM2FNcWJiV2pubg?oc=5", "source_name": "Market source", "published_at": "2026-03-27T07:00:00+00:00", "published_display": "27 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novartis India shares soar 20% as Swiss parent plans full exit in Rs 1,446 crore deal", "summary": "", "url": "https://news.google.com/rss/articles/CBMi-AFBVV95cUxQOWRNMXAwUjJNUWx0NHYwaXB3Qmh5UDItM1BzR2hBMjNyV3hHV2IwZ1lITUVwdjJRak94THdEaWFvU09tMUZubEwwejN6T2ZfdXNQdnU2REhkV3FrRzJicFlsM3lacmF3ZnRpdUtheEk2Y0E5Z1B4QW81UTVfRDV2VUtNZ0tpdjlrWjdodGwtSHZCdkc1TlRsUlgtQTJRYWl3cTBtaXE1SVVxd1lSelBSdUVya1JndWdDZi1VNXkwNUdpN2JvMGpoOXJlYlNOeFUwS3dDRUtocE50MExkZXRNclJaWDAwZHBxVGp6YjRxRHJNdmRTeFBENtIB_gFBVV95cUxQQjRfTjBUaVdDcGxPSzIxVmZMUDRqUWdra0pkdUZSM0UtWm1FY2w4dVNqZGNNTlYyRmI0Vm9uOGVfaWljSXJJWkd1NG40UWRlUVlLUmpWbzZVblR4dzJuUnY2ODRTaW9UaV96bGFLRzJjaU41a1B4Y1BiMHRxMTNHRjJhLXRWWm1pVVlTWUxRLU5jSno2dV8xTlhRT1JMcXJ4TzA3V1lTSlg5VXNGOE1xRTZOSHhVNm1TdW0xcWw0Nk9ENDZxNmtjdGFSWGhadkljY2hRbHA3UC1vMUl6a1B0T3BSckVEdDNlWUVnQV9Nb2gyVVhBd0gzRkhNMjBkdw?oc=5", "source_name": "The Economic Times", "published_at": "2026-02-20T08:00:00+00:00", "published_display": "20 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novartis India shares zoom on Swiss parent\u2019s \u20b91,446 cr. exit plan", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The Hindu", "published_at": "2026-02-20T08:00:00+00:00", "published_display": "20 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novartis shares hit 20% upper circuit as Swiss parent to sell entire stake", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Business Standard", "published_at": "2026-02-20T08:00:00+00:00", "published_display": "20 Feb 2026 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Should Vanrafia Kidney Data and Dividend Move Reshape the Novartis (SWX:NOVN) Autoimmune Investment Case?", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxOeHR5SFlIS2Q4QlNNLWItS1pHd0F4WnhzY3lGYWszUFo0WUc0TjR4akQ0RnVzMU93Sk5RZEtDekN0WUVGb0U0aF83by1zUDlhZU0zQ1lzNGlYbjNValM0cGtVRDg5SzlPdHVKN19zSXFEcmxuemhKcjA2ZjNmWVlWSmwwMnQtbG8?oc=5", "source_name": "Market source", "published_at": "2026-02-15T08:00:00+00:00", "published_display": "15 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is It Too Late To Consider Novartis (SWX:NOVN) After Strong Multi\u2011Year Share Gains?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiggFBVV95cUxOcjd5c28tUDdHbFRneEQ1OTFGU01IOEUzaVFUWEZEWmlyYVFLX1p1aHo4ZEdKaTZ1UkE1LVpnZEU3TUhNZVAyandac0Y3SjhteGVwNlB0WDJySG9HdzZTY0RNWU9PN0JxN3NtWkVSazFPU1ZUWGZsZkxxaXBvclpiQWVn?oc=5", "source_name": "Market source", "published_at": "2026-02-14T08:00:00+00:00", "published_display": "14 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novartis' (VTX:NOVN) Shareholders Will Receive A Bigger Dividend Than Last Year", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxPek5mLWVIZDRPSmRpWTVmaHE0Vi1OUVVxS1dhSHRwR0E0WkdYbXpQOTVFVXBXWmdUUTkydjBUS3l1U1FSa3JNOHV2YVlhX3dkZ1FvbkFUNjFpa2pZUnA3dXdXX2hMVUFVVXkyZmNvRC13QXQ3aEZTLXFBai1CUE11aG0zSGRJVDlpamtjUw?oc=5", "source_name": "Market source", "published_at": "2026-02-08T08:00:00+00:00", "published_display": "08 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novartis AG (VTX:NOVN) Just Reported Full-Year Earnings: Have Analysts Changed Their Mind On The Stock?", "summary": "", "url": "https://news.google.com/rss/articles/CBMie0FVX3lxTE9lMEVYUDY1clJIN085NXQ3Vkh5RjRyZWNoYlZKQ2lZMktBWWtlVjZSSzJCT1JJOGJHVjM3dWZnYjdsaFU4WVhMNk53NFpHSzVfXzJpSzk3RW5WZVJ3LVhhTzU0cm5ad2djc0VOR1VoSS1uei1VSUloTkkzMA?oc=5", "source_name": "Market source", "published_at": "2026-02-07T08:00:00+00:00", "published_display": "07 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Novartis (SWX:NOVN) Attractive After Strong Multi Year Share Price Performance", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxQWVNCRzJaY3lpcDhHUmlGdXRFUXZ4MDVDdmlSdV9VSTlXUDBvR2pmcnB5Z0VCcUszdWFmTWhRU0x0QkpiU3dMenhMUlFIM3JSNmplc3pVQ1J3RDZ5dDBCaFdoekJnU2k5dUFocUlZRnZxMFFpTVZFNXRoRFlkeGRoQnlYaW9kUDk3?oc=5", "source_name": "Market source", "published_at": "2026-01-31T08:00:00+00:00", "published_display": "31 Jan 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is It Time To Reconsider Novartis (SWX:NOVN) After Its Recent Share Price Gains?", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxPUkpBYjVuUTlaaE9KcUhIc0tkTEZ4U3BWZG41V3pjazRVb1gxT0M0MVY3YnB5SThubkVRR3AzaERZazBsUnI2MmZQZHN6V2ZqRnJISGhQX3hLS0Y3anVqTGFoeVlGbFpwMmVicHYtZ0hURS14cU9iakZmamdqc1RzWFg4bVJPQQ?oc=5", "source_name": "Market source", "published_at": "2026-01-10T08:00:00+00:00", "published_display": "10 Jan 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novartis Stock Forecast: What\u2019s Driving NOVN and Where It Could Go Next", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxQWWI0MXNIMk9WZkUwQ1FSTHlXTlVrdURVaVp2ZXZNMUlqU2FKbUdFQnpsdVk0TGR0NnRGakNqbkx2TmRKRzlrdkVzazVxM2JfczF6Ym5taVEwblpQdndVU1p3QVczbzUyOHhvYXFfQUZJOHFKVGxqWjVMWVFqbWR1bzZRTG1FaUxEMVBvMGtoal9yYWpZUjJieDR3MA?oc=5", "source_name": "TIKR.com", "published_at": "2025-10-24T07:00:00+00:00", "published_display": "24 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 89, "total_relevant": 39, "sentiment_summary": {"positive": 9, "negative": 2, "neutral": 28, "score": 53, "total": 39, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 79, "events": [{"event": "general", "label": "Market update", "weight": 12.1, "count": 22}, {"event": "earnings", "label": "Earnings", "weight": 3.3, "count": 6}, {"event": "deals", "label": "Deals and strategy", "weight": 1.8, "count": 2}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 1.65, "count": 3}, {"event": "capital_return", "label": "Capital return", "weight": 1.65, "count": 3}, {"event": "analyst", "label": "Analyst action", "weight": 0.55, "count": 1}], "positive_events": 9, "negative_events": 2}, "market_context": {"has_market_context": true, "latest_close": 124.28, "latest_week": "2026-07-10", "one_week_move": -2.8, "four_week_move": 1.8, "twelve_week_move": 4.6, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 0.320869, "market_dynamics_buy_signal": false, "relative_strength": 3.658307, "fair_value_gap": 33.0, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "undecided", "expectation_probability": 53.708, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-2.8% over one week, +1.8% over four weeks, trend active, and materially above fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 61, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 16}, {"label": "ad-hoc-news.de", "count": 14}, {"label": "simplywall.st", "count": 3}, {"label": "TradingKey", "count": 1}, {"label": "GuruFocus", "count": 1}, {"label": "The Economic Times", "count": 1}, {"label": "The Hindu", "count": 1}, {"label": "Business Standard", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 39}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 22}, {"label": "Earnings", "count": 6}, {"label": "Regulatory and legal", "count": 3}, {"label": "Capital return", "count": 3}, {"label": "Deals and strategy", "count": 2}, {"label": "Analyst action", "count": 1}, {"label": "Macro sensitivity", "count": 1}, {"label": "Guidance", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "53/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "79/100 classification confidence."}, {"label": "Company focus", "value": "39", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "2", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "-2.8% over one week, +1.8% over four weeks, trend active, and materially above fair value."}, {"label": "Latest direct headline", "value": "Positive", "tone": "positive", "text": "Is Novartis (SWX:NOVN) Undervalued As EU Expands Approval For Its Gene Therapy?"}], "updated_at": "2026-07-17T10:14:09.257063+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}